Targeting the p53-FOXO4 Axis: In senescent cells, the protein FOXO4 binds to p53 and sequesters it in the nucleus, preventing p53 from triggering cell death
Aug 9 : Nearly three years after first winning accelerated FDA approval of Gavreto (pralsetinib) in metastatic non-small cell lung cancer (NSCLC) with RET fusions, Genentech (Roche) and Blueprint Medicines announced the drugs conversion to full approval
(2) the bi-functional catalase-peroxidases, members of a protein family predominantly present among eubacteria and archaea with only two evolutionary branches found in eukaryotic organisms
Discussion Pathological myocardial hypertrophy is characterized by the death of myocardial cells and concomitant fibrosis that ultimately leads to reductions in systolic and diastolic function, contributing to the onset and progression of heart failure
Tissue Repair Support : Preclinical studies suggest involvement in cellular signaling related to tissue healing, which connects to recovery from muscle, tendon, and ligament injuries, reflecting key benefits of BPC-157 in experimental recovery models